A61K 51/084
The peptide being oxytocin
Official title: {the peptide being oxytocin}
A61K51/084 (The peptide being oxytocin) appears on 4 US grants and 5 published applications in this corpus.
Search patents in A61K- Granted patents
- 4
- Published applications
- 5
- Assignees
- 7
- Inventors
- 13
- Latest grant
- 11 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 2 | 1 |
| 2025 | 1 | 1 |
By publication year.
Recent patents
- Labeled oxytocin and method of manufacture and use11 Nov 2025US 12,466,855 B2Aarhus University
- Magnesium-containing oxytocin formulations and methods of use3 Dec 2024US 12,156,897 B2Tonix Pharma Limited
- Labeled oxytocin and method of manufacture and use30 Apr 2024US 11,970,554 B2Aarhus University
- Vinylsulfone-based 18F-labeling compositions and methods and uses thereof12 Nov 2019US 10,471,161 B2City of Hope
- Magnesium-containing oxytocin formulations and methods of use16 Oct 2025US 2025/0319153 A1Tonix Pharma Limited
- Labeled oxytocin and method of manufacture and use12 Sep 2024US 2024/0301004 A1Aarhus University
- Labeled oxytocin and method of manufacture and use7 Jan 2021US 2021/0002331 A1Aarhus University
- Magnesium-containing oxytocin formulations and methods of use13 Jun 2019US 2019/0175686 A1Trigemina, Inc.
- Vinylsulfone-based 18F-labeling Compositions and Methods and Uses Thereof21 Jan 2016US 2016/0015838 A1University of Southern California - Usc Stevens
Most cited
By later US patents